NSESpurt in Volume9 Sept 2026 · 9 Sept 2026, 10:49 am
Spurt in Volume
Astec LifeSciences Limited · ASTEC
✦ AI SummaryRegulatory
Astec LifeSciences Limited has responded to a notice from the National Stock Exchange regarding a significant increase in volume, confirming compliance with listing regulations and stating that there are no developments requiring mandatory disclosure.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Significant increase in volume has been observed in Astec LifeSciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Astec LifeSciences Limited has submitted their response.
Attachments (1)
📄pdf
Download →
ASTEC_09092026104812_NSEReplyIncreaseVolume09092026.pdf
View document text
Date: 9th September, 2026
National Stock Exchange of India Limited
Exchange Plaza, Bandra Kurla Complex,
Bandra (East), Mumbai - 400 051
NSE Symbol: “ASTEC”
Dear Sir / Madam,
Sub.: Reply on Significant Increase in the Volume of Security across Exchanges, in the recent past
Ref.: Your Notice Ref. No. NSE/CM/Surveillance/17517 dated 8th September, 2026
With reference to your captioned Notice bearing Ref. No.: NSE/CM/Surveillance/17517 dated 8th
September, 2026, we wish to inform you that as a Listed Company, we are conscious of our responsibility
to disseminate to the Stock Exchanges, information that could have an impact on the price of the
Company’s shares. Consistent with this approach, we have been promptly disseminating to the Stock
Exchanges, events or information which are required to be disclosed pursuant to the Regulation 30 of the
Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations,
2015 (“the Listing Regulations”).
We hereby confirm that we are in compliance with respect to disclosures that are required to be made
under the Listing Regulations and also confirm that there are no developments that have taken place
requiring mandatory disclosure under Listing Regulations or the Securities and Exchange Board of India
(Prohibition of Insider Trading) Regulations, 2015 (“PIT Regulations”).
Please be assured that as a responsible corporate citizen we would fully comply with our obligations under
the Listing Regulations and / or PIT Regulations and would make appropriate disclosures as mandated
under the applicable regulations as and when required.
Kindly take the above information on your records.
Thanking you,
Yours sincerely,
For Astec LifeSciences Limited
Tejashree Pradhan
Company Secretary & Compliance Officer
(FCS 7167)